Discounted Cash Flow (DCF) Analysis Unlevered

Guardion Health Sciences, Inc. (GHSI)

$0.1556

-0.01 (-5.87%)
All numbers are in Millions, Currency in USD
Stock DCF: -406.50 | 0.1556 | overvalue

Operating Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.440.940.901.897.2316.3336.8983.30188.11424.79
Revenue (%)
EBITDA -5.16-7.47-9.99-8.34-23.96-125.87-284.24-641.89-1,449.54-3,273.41
EBITDA (%)
EBIT -5.28-7.77-10.62-8.56-24.75-130.78-295.33-666.93-1,506.08-3,401.10
EBIT (%)
Depreciation 0.120.300.630.220.784.9111.0925.0456.55127.69
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 4.740.6711.128.529.0996.74218.47493.361,114.132,515.97
Total Cash (%)
Account Receivables 0.070.030.080.011.411.583.578.0718.2241.14
Account Receivables (%)
Inventories 0.150.360.310.380.374.359.8322.2050.14113.22
Inventories (%)
Accounts Payable 0.310.410.130.610.245.3912.1727.4862.05140.12
Accounts Payable (%)
Capital Expenditure -0.04-0.31-0.17-0.04-0.07-2.08-4.69-10.59-23.92-54.02
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 0.1,556
Beta 0.794
Diluted Shares Outstanding 142.13
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 6.627
Total Debt 0.03
Total Equity 22.12
Total Capital 22.14
Debt Weighting 0.12
Equity Weighting 99.88
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.440.940.901.897.2316.3336.8983.30188.11424.79
EBITDA -5.16-7.47-9.99-8.34-23.96-125.87-284.24-641.89-1,449.54-3,273.41
EBIT -5.28-7.77-10.62-8.56-24.75-130.78-295.33-666.93-1,506.08-3,401.10
Tax Rate 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIAT -5.28-7.77-10.62-8.56-24.75-130.78-295.33-666.93-1,506.08-3,401.10
Depreciation 0.120.300.630.220.784.9111.0925.0456.55127.69
Accounts Receivable -0.04-0.050.07-1.40-0.17-1.99-4.49-10.15-22.92
Inventories --0.200.05-0.070.02-3.99-5.48-12.37-27.94-63.09
Accounts Payable -0.10-0.280.48-0.375.156.7815.3134.5778.07
Capital Expenditure -0.04-0.31-0.17-0.04-0.07-2.08-4.69-10.59-23.92-54.02
UFCF -5.20-7.84-10.45-7.91-25.79-126.96-289.62-654.04-1,476.97-3,335.37
WACC
PV UFCF -119.06-254.73-539.47-1,142.50-2,419.62
SUM PV UFCF -4,475.37

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 6.63
Free cash flow (t + 1) -3,402.07
Terminal Value -73,478.90
Present Value of Terminal Value -53,304.71

Intrinsic Value

Enterprise Value -57,780.08
Net Debt -4.07
Equity Value -57,776.01
Shares Outstanding 142.13
Equity Value Per Share -406.50